Table III.
Association between the expression of PTPRZ1 and PTN and patient clinicopathological features.
| PTN | PTPRZ1 | ||||
|---|---|---|---|---|---|
| Feature | No. | Mean ± SD | P-value | Mean ± SD | P-value |
| ER | |||||
| Positive | 133 | 137.11±100.33 | 0.079 | 364.38±381.03 | 0.337 |
| Negative | 192 | 211.52±176.14 | 464.47±368.00 | ||
| PR | |||||
| Positive | 115 | 147.71±105.44 | 0.240 | 401.84±403.62 | 0.754 |
| Negative | 210 | 199.39±172.56 | 435.56±361.02 | ||
| Her-2 | |||||
| Positive | 78 | 143.72±47.66 | 0.316 | 425.94±366.50 | 0.980 |
| Negative | 247 | 193.09±172.78 | 422.98±379.66 | ||
| ALN | |||||
| Positive | 168 | 195.82±195.50 | 0.472 | 394.61±313.51 | 0.557 |
| Negative | 157 | 165.46±89.64 | 455.02±432.42 | ||
| Tumor size | |||||
| <2 cm | 132 | 187.00±109.29 | 464.22±431.89 | 0.568 | |
| 2–5 cm | 157 | 192.75±194.84 | 0.486 | 422.82±360.06 | |
| >5 cm | 36 | 109.92±46.38 | 278.92±107.37 | ||
| Menopause | |||||
| Yes | 138 | 154.72±95.08 | 0.278 | 431.70±194.71 | 0.893 |
| No | 157 | 200.80±184.25 | 417.75±362.76 | ||
PTPRZ1, protein tyrosine phosphatase ζ; PTN, pleiotrophin; ER, estrogen receptor, PR, progesterone receptor; ALN, axillary lymph node.